Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

The Second Xiangya Hospital of Central South University | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Hui Li began her academic journey with a strong interest in internal medicine, which laid the foundation for her later specialization. Her doctoral studies at Central South University equipped her with in-depth knowledge of the mechanisms of disease progression and clinical applications. These formative years shaped her scientific curiosity and commitment to advancing research that bridges clinical practice and basic science.

Professional Endeavors

Prof. Li currently serves as the Associate Director of the Institute of Anesthesiology at Central South University, where she has taken on leadership responsibilities in guiding both clinical and academic teams. She has successfully secured competitive national research funding and has consistently contributed to the advancement of anesthesiology and perioperative medicine. Her role also extends to mentoring young researchers and postgraduate students, thereby strengthening the academic environment of her institution.

Contributions And Research Focus

Her primary research focus revolves around perioperative organ protection and neuro immune regulation. Prof. Li has explored the underlying biological mechanisms that influence patient outcomes during and after surgery, with an emphasis on protecting vital organs from damage. Her work highlights the intricate interaction between the nervous and immune systems in the perioperative setting, contributing valuable insights to both anesthesiology and internal medicine.

Impact And Influence

Prof. Li has published extensively in reputable international journals, including contributions to highly respected platforms such as Nature Communications, Cell Death and Disease, and Cardiovascular Diabetology. Through these publications, her findings have gained global recognition and have provided new directions for clinical research. Her influence extends beyond her own institution, as her research is frequently cited and built upon by other scholars in the field.

Academic Cites

The scholarly impact of Prof. Li is evident in the citations her work has received in the global academic community. Her contributions are referenced in multiple studies across anesthesiology, immunology, and cardiovascular research. This academic visibility underscores the relevance and applicability of her research in interdisciplinary domains.

Legacy And Future Contributions

Prof. Li’s academic legacy lies in her ability to connect molecular insights with practical clinical applications. Her work on organ protection and neuro immune pathways not only advances the field of anesthesiology but also has broader implications for perioperative care and long term patient recovery. Looking ahead, her continued leadership and innovative studies are expected to shape future standards in patient safety, anesthesia practices, and translational medicine.

Conclusion

Prof. Hui Li stands as a distinguished academic whose career reflects dedication to clinical innovation and scientific excellence. With her leadership in anesthesiology, her significant body of research, and her growing academic influence, she continues to contribute meaningfully to both scientific advancement and medical practice. Her trajectory promises further breakthroughs that will enhance patient outcomes and inspire future generations of researchers.

Notable Publications

"Random forest algorithm for predicting postoperative hypotension in oral cancer resection and free flap reconstruction surgery"

Authors: Shuiting Zhang, Yanling Zhang, Xinyu Ouyang, Hui Li , Ruping Dai
Journal: Scientific Reports
Year: 2025

"Monocytes perturbation implicated in the association of stress hyperglycemia with postoperative poor prognosis in non-diabetic patients with Stanford type-A acute aortic dissection"

Authors: Shuai Zhao, Di Fu, Wei Luo, Wei-Yun Shen, Xue-Mei Miao, Jia-Ying Li, Jing-Ying Yu, Qian Zhao, Hui Li, Ru-Ping Dai
Journal: Cardiovascular Diabetology
Year: 2024

Qiong Wu | Heart Failure | Best Paper Award

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Qiong Wu | Heart Failure | Best Paper Award

Longhua Hospital | Shanghai University of TCM | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qiong Wu began her academic journey in Traditional Chinese Medicine, completing her Bachelor’s degree in Acupuncture and Massage from Shanghai University of Traditional Chinese Medicine. She continued her education with a Master’s degree in Clinical Integrated Traditional Chinese and Western Medicine, further strengthening her expertise in bridging conventional and traditional medical practices. Her academic advancement culminated with a doctoral degree in Chinese Medicine, where she specialized in cardiovascular applications of integrated treatment approaches.

Professional Endeavors

Her professional trajectory has been closely linked with Longhua Hospital, affiliated to Shanghai University of Traditional Chinese Medicine. Beginning as a physician in multiple specialties including cardiology, neurology, respiratory medicine, nephrology, and endocrinology, she gained wide clinical exposure. Progressing into academic medicine, she served as an Assistant Professor in the Cardiovascular Department and is currently an Associate Professor in the same institution. These roles have allowed her to combine clinical service, academic teaching, and intensive research.

Contributions And Research Focus

Qiong Wu has accumulated nearly a decade of research experience centered on cardiovascular diseases such as dilated cardiomyopathy, ischemic heart disease, and hypertension. Her primary focus lies in pharmacological interventions, herb-drug interactions, and the integrated prevention of ventricular remodeling. She has developed specialized expertise in cardiomyocyte apoptosis, ventricular remodeling, and lymphatic vessel regeneration. She is proficient in advanced laboratory methodologies such as protein purification, RNA isolation, western blotting, immunohistochemistry, and cell culture, underscoring her capacity for translational cardiovascular research.

Impact And Influence

Her research has been recognized with competitive funding from prestigious sources, including the National Natural Science Foundation of China, the Shanghai Municipal Health Commission, and institutional programs at her university and affiliated hospital. These projects reflect both her leadership as a principal investigator and her commitment to bridging traditional medicine with modern biomedical science. Her contributions to clinical research include randomized, double-blind clinical studies on Traditional Chinese Medicine formulations for conditions such as atrial fibrillation and dilated cardiomyopathy.

Academic Cites

In addition to research articles, she has contributed significantly to scholarly literature through editorial roles. She has served as an associate editor for a comprehensive text on the integrated treatment of dilated cardiomyopathy and as a co-editor for a volume on chronic cor pulmonale. Her academic writings and publications not only disseminate knowledge but also serve as valuable references for the integration of traditional Chinese and Western medicine approaches in cardiovascular care.

Legacy And Future Contributions

Qiong Wu’s work exemplifies the convergence of clinical practice, experimental research, and traditional medicine innovation. Her patent applications on Chinese medicine compositions for atrial fibrillation and cardiomyopathy demonstrate her translational impact and potential for therapeutic innovation. As an active member of multiple professional committees within China, she is contributing to the shaping of national discourse on cardiovascular medicine, drug research, and clinical pharmacy in Traditional Chinese Medicine. Her legacy is likely to be defined by her role in validating and modernizing traditional formulations through rigorous clinical and experimental frameworks.

Conclusion

Qiong Wu stands out as an accomplished academician and researcher in the field of integrated cardiovascular medicine. With a strong foundation in both Traditional Chinese Medicine and modern biomedical approaches, she has advanced understanding in areas such as ventricular remodeling, herb-drug interactions, and clinical treatment of complex cardiovascular conditions. Her leadership in funded projects, editorial contributions, and patents positions her as an influential figure shaping the integration of traditional and contemporary practices. Looking forward, her ongoing research and clinical collaborations are expected to make lasting contributions to the global field of cardiovascular medicine.

Notable Publications

"Kuoxin Decoction Alleviated Left Ventricular Remodeling by Inhibiting Cardiomyocyte Apoptosis Through ASK1/JNK/Cx43 Signaling Pathway in cTnTR141W Transgenic Mice and in vitro"

Authors: Mengjiao Ma, Hua Fan, Yidan Dong, Tianyi Feng, Longping Peng, Maolin Zhou, Feifei Liu, RueyJyh Lee, Rongxue Wu, Qiong Wu et al.
Journal: Drug Design, Development and Therapy
Year: 2025

"Regulatory Effects of Zhenxin Formula in Treating Doxorubicin-Induced Heart Failure: Network Pharmacology and Animal Experimental Verification"

Authors: Qiong Wu, Hao Wang, You Wang, Jun Du, Bo Li, Xiao-Na Gan, Chen-Yang Liu, Jing Liang, Chang Liu, Min Cao
Journal: Drug Design, Development and Therapy
Year: 2025

"MMP3 at the Crossroads: Linking Molecular Pathways to Disease Diagnosis and Therapy"

Authors: Jing Jiang, Qiong Wu, Snekha Rajasekaran, Rongxue Wu
Journal: Pharmacological Research
Year: 2025

"Remote Ischaemic Pre-conditioning, Kidney Injury, and Outcomes After Coronary Angiography and Intervention: A Randomized Trial"

Authors: Ping Jia, Gang Zhao, Yuli Huang, Zhouping Zou, Qi Zeng, Weize Chen, Ting Ren, Yang Li, Xiaoyan Wang, Tingting Kang et al.
Journal: European Heart Journal
Year: 2025

"Astragalus Polysaccharide Protects Against Cardiac Injury in a tnnt2a Mutant Zebrafish Model of Dilated Cardiomyopathy"

Authors: Chang Zhou, Hui Zhao, Longping Peng, Yidan Dong, Qiong Wu, Xu Wang, Yingjia Xu, Youhua Wang
Journal: BMC Complementary Medicine and Therapies
Year: 2025

"Efficacy and Safety of Kuoxin Formula in the Treatment of Dilated Cardiomyopathy-Related Heart Failure: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial"

Authors: Qiong Wu, Shiying An, RueyJyh Lee, Dongwen Gao, Yinyifan Zhou, Longping Peng, Chunrui Hu, Lei Yao, Chang Zhou, Li Zhou et al.
Journal: International Journal of General Medicine
Year: 2024

"Comparison of Two Single-Pill Dual Combination Antihypertensive Therapies in Chinese Patients: A Randomized, Controlled Trial"

Authors: Qi-Fang Huang, Di Zhang, Yihong Luo, Kun Hu, Qiong Wu, Hailong Qiu, Fei Xu, Mei-Ling Wang, Xin Chen, Yan Li et al.
Journal: BMC Medicine
Year: 2024

"A Retrospective Study of Pupingqinghua Prescription Versus Lianhuaqingwen in Chinese Participants Infected With SARS-CoV-2 Omicron Variants"

Authors: Yidan Dong, Wei Zhai, Bangjiang Fang, Chenyang Liu, Suyun Yuan, Youhua Wang, Qixiang Song, Hai Li, Bin Chen, Dan Cui et al.
Journal: Frontiers in Pharmacology
Year: 2022

 

Mingfu Wu | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Mingfu Wu | Congenital Heart Defects | Best Researcher Award

University of Houston | United States

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Mingfu Wu began his academic journey with a strong commitment to biomedical sciences, developing a deep interest in the processes underlying heart development. His early pursuits were guided by curiosity and rigorous training, building a strong foundation in developmental biology and cardiovascular research. This period shaped his passion for investigating the molecular and cellular mechanisms that contribute to heart formation.

Professional Endeavors

Over the course of his career, Mingfu Wu has established himself as a respected researcher and academic leader. He has held important academic positions that allowed him to balance research, teaching, and scientific service. His professional journey reflects dedication to advancing knowledge, fostering collaboration, and contributing to the broader scientific community through peer review, academic service, and mentoring.

Contributions And Research Focus

The research focus of Mingfu Wu centers on uncovering the molecular mechanisms of cardiac development and disease. His pioneering studies have advanced understanding of trabecular morphogenesis, epicardial development, and the role of regulatory proteins in heart formation. His more recent discovery of tunneling nanotube-like structures that mediate long-distance intercellular communication highlights his ability to pursue groundbreaking directions in developmental biology.

Impact And Influence

The impact of Mingfu Wu’s work is evident in its wide recognition within the scientific community. His findings have provided critical insights that shaped further research in developmental cardiology, regenerative medicine, and related disciplines. Beyond his publications, his influence is visible in the success of students and postdoctoral researchers he has mentored, many of whom have been recognized for their contributions.

Academic Cites

Mingfu Wu’s research has been consistently cited by peers, underscoring its importance and relevance. His work has been presented at national and international conferences, incorporated into the academic dialogue of cardiovascular biology, and acknowledged in leading scientific journals. His contributions as a reviewer and evaluator for scholarly bodies further reflect the trust placed in his expertise.

Legacy And Future Contributions

Mingfu Wu’s legacy rests on his ability to combine innovative scientific discovery with impactful mentorship and academic service. Looking ahead, his future contributions are expected to move increasingly toward translational research, bridging the gap between basic biological understanding and clinical applications. Through continued interdisciplinary collaboration and mentorship, his work will leave a lasting imprint on cardiovascular research.

Conclusion

In conclusion, Mingfu Wu represents the qualities of a distinguished scholar and innovator. His research achievements, academic influence, and commitment to scientific advancement make him an outstanding candidate for the Best Researcher Award. With a legacy of impactful discoveries and a promising future of translational contributions, he stands as a leader whose work will continue to shape the field of cardiovascular and developmental biology.

Notable Publications

"Tunneling Nanotube-Like Structures Regulate Distant Cellular Interactions During Heart Formation"

Authors: Lianjie Miao, Yangyang Lu, Anika Nusrat, Guizhen Fan, Shaohua Zhang, Luqi Zhao, Chia-Ling Wu, Hongyan Guo, Trang Le Nu Huyen, Yi Zheng, Zhen-Chuan Fan, Weinian Shou, Robert J Schwartz, Yu Liu, Ashok Kumar, Haixin Sui, Irina I Serysheva, Alan R Burns, Leo Q Wan, Bin Zhou, Sylvia M Evans, Mingfu Wu*
Journal: Science
Year: 2025

"β1 Integrins Regulate Cellular Behaviors and Cardiomyocyte Organization During Ventricular Wall Formation"

Authors: Lianjie Miao, Yangyang Lu, Anika Nusrat, Luqi Zhao, Micah Castillo, Yongqi Xiao, Hongyang Guo, Yu Liu, Preethi Gunaratne, Robert J Schwartz, Alan R Burns, Ashok Kumar, C Michael DiPersio, Mingfu Wu*
Journal: Cardiovascular Research
Year: 2024

"The IRE1α/XBP1 Signaling Axis Drives Myoblast Fusion in Adult Skeletal Muscle"

Authors: Joshi AS, Tomaz da Silva M, Roy A, Koike TE, Wu M, Castillo MB, Gunaratne PH, Liu Y, Iwawaki T, Kumar A
Journal: EMBO Reports
Year: 2024

"Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice"

Authors: Sun B, Rouzbehani OMT, Kramer RJ, Ghosh R, Perelli RM, Atkins S, Fatahian AN, Davis K, Szulik MW, Goodman MA, Hathaway MA, Chi E, Word TA, Tunuguntla H, Denfield SW, Wehrens XHT, Whitehead KJ, Abdelnasser HY, Warren JS, Wu M, Franklin S, Boudina S, Landstrom AP
Journal: Circulation: Heart Failure
Year: 2023

"Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead"

Authors: Datta S, Cao W, Skillman M, Wu M*
Journal: International Journal of Molecular Sciences
Year: 2023

"Temporal Regulation of TAK1 to Counteract Muscular Dystrophy"

Authors: Anirban Roy, Tatiana Koike, Aniket Joshi, Meiricris Tomaz Da Silva, Kavya Mathukumalli, Mingfu Wu, Ashok Kumar
Journal: JCI Insight
Year: 2023

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Jianning Zhang | Atherosclerosis | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Jianning Zhang | Atherosclerosis | Best Researcher Award

Chinese PLA General Hospital | China

Author Profile:

Orcid

Scopus

🧠🌟 ICON OF NEUROSURGERY: PROFESSOR JIANNING ZHANG 🌟🧠

🎓 EARLY ACADEMIC PURSUITS

Professor Jianning Zhang began his medical journey driven by a profound interest in neurological sciences. His early academic endeavors built a solid foundation, enabling him to become a future leader in neurosurgery. Through diligent study, clinical excellence, and deep curiosity, he prepared himself to tackle the most complex challenges in brain and spinal surgery.

🏥 PROFESSIONAL ENDEAVORS

Prof. Zhang currently serves as the Director of the Department of Neurosurgery at PLA General Hospital . Holding the military rank of Major General (Professional Technical) , he is a respected Chief Physician, Professor, and Doctoral Supervisor .

Key Leadership Roles:

  • Chairman, Neurotrauma Branch, China International Exchange and Promotive Association for Medical and Health Care

  • Vice Chairman, Neurosurgery Professional Committee of the PLA

  • Associate Editor, Medical Journal of Chinese People's Liberation Army & Journal of Clinical Neurosurgery

  • Editorial Board Member, 10+ journals including Chinese Journal of Neurosurgery

His professional presence bridges clinical care, academic scholarship, and military medical advancement.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ATHEROSCLEROSIS

A true innovator in neurotrauma and surgical science, Prof. Zhang has led over 20 major research projects, including:

  • National 863 Program Projects

  • Military Logistics Research Projects

  • National Natural Science Foundation Projects

  • Beijing Capital Characteristic Clinical Projects

Surgical Specialties:

  • Minimally invasive microsurgery

  • Neuronavigation-guided procedures

  • Brainstem tumors

  • Skull base tumors

  • Craniocervical junction malformations

  • Cavernous sinus tumors

  • Intracranial aneurysms

  • Cerebral AVMs

  • Intramedullary spinal cord tumors

🏆 IMPACT AND INFLUENCE

Prof. Zhang’s impact is reflected through numerous national and institutional honors:

Awards & Honors:

  • National Science and Technology Progress Award (Second Class)

  • Chinese Medical Science and Technology Award (First Class)

  • PLA Science and Technology Progress Awards (First & Second Class)

Special Recognitions:

  • Wang Zhongcheng Academic Achievement Award in Neurosurgery (2014)

  • National “Bethune-Style Good Doctor” (4th Session, 2020)

  • “People’s Renowned Doctor • Outstanding Contribution” (2022)

He also receives special government allowances from the State Council and first-class technical cadre allowances from the PLA.

📚 ACADEMIC CITES & SCHOLARLY WORK

As a prolific researcher, Prof. Zhang has published over 300 academic papers , primarily as first or corresponding author. His contributions are widely cited across neurosurgical research, shaping both clinical guidelines and surgical innovations.

His editorial roles and research citations place him among the most respected academic voices in neurosurgery across China and internationally.

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Jianning Zhang’s work continues to inspire future generations of neurosurgeons, educators, and researchers. His legacy is one of innovation, leadership, and service to humanity and national health development.

As he continues to shape the future of neurosurgery, his dedication to research and patient care remains unwavering — ensuring safer, more effective treatments for even the most complex neurological disorders.

📑 NOTABLE PUBLICATIONS

"The Transtemporal Isthmus Approach for Insular Glioma Surgery"

Authors: G Sun, X Shu, D Wu, K Zhao, Z Xue, G Cheng, L Chen, J Zhang
Journal: Operative Neurosurgery
Year: 2025

"Impact of celastrol on mitochondrial dynamics and proliferation in glioblastoma"

Authors: L Liang, W Lv, G Cheng, M Gao, J Sun, N Liu, H Zhang, B Guo, J Liu, Y Li, S Xie, J Wang
Journal: BMC Cancer
Year: 2025

Xinyi Huang | Obesity | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xinyi Huang | Obesity | Best Researcher Award

Gaozhou people's hospital | China

Author Profile:

Orcid

🌟 DR. XINYI HUANG: A DEDICATED PHYSICIAN AND CARDIOVASCULAR RESEARCHER

🎓 EARLY ACADEMIC PURSUITS

Dr. Xinyi Huang began her medical journey at Guangdong Medical University, where she pursued a Bachelor of Medicine in Anesthesiology from 2015 to 2020. During her undergraduate years, she displayed exceptional academic prowess and leadership abilities. She actively participated in academic competitions, earning several accolades such as the Excellence Award in the 4th National Undergraduate Anesthesiology Knowledge Competition and multiple school-level awards in anesthesiology imaging professional skill contests.

Her strong academic foundation led her to further her studies at Sun Yat-sen University, one of China’s leading medical institutions. There, she specialized in Internal Medicine (Cardiovascular Medicine) and completed her Master of Medicine at Sun Yat-sen Memorial Hospital between 2020 and 2023.

🏥 PROFESSIONAL ENDEAVORS

Dr. Huang’s clinical career commenced as a Resident Doctor at Sun Yat-sen University, where she honed her expertise in cardiovascular medicine. Following this, she joined Gaozhou People's Hospital in Guangdong in October 2024, where she currently serves in the Cardiovascular Department.

Her clinical work focuses on the diagnosis and management of atrial fibrillation, obesity-related cardiovascular risks, and other complex cardiovascular conditions, reflecting her research interests.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON OBESITY

Dr. Huang has actively contributed to the growing body of cardiovascular research. Her primary research areas include Atrial Fibrillation, particularly in patients with obesity and heart failure with preserved ejection fraction (HFpEF). She has co-authored significant academic papers addressing the association between body mass index (BMI), abdominal obesity, and the incidence of atrial fibrillation in heart failure patients.

Her research extends to exploring lipoprotein subgroups, such as HDL subtypes, and their influence on vascular inflammation in hypertensive patients, highlighting her multidisciplinary approach linking metabolism and cardiovascular health.

🌍 IMPACT AND INFLUENCE

Dr. Huang’s work contributes meaningfully to understanding how obesity and metabolic factors drive cardiovascular conditions like atrial fibrillation. Her research has been published in reputable journals such as Current Medical Research and Opinion and the Chinese Journal of Arteriosclerosis, enhancing clinical insights into cardiovascular disease prevention and management.

Her awards in anesthesiology and cardiovascular studies, along with her leadership roles and volunteer contributions, demonstrate her dedication to advancing both medical practice and community health.

📚 ACADEMIC CITES

Key Publications:

  1. Huang X, et al. “Association of Body Mass Index and Abdominal Obesity with Incidence of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction.” Current Medical Research and Opinion, 2025.

  2. Huang Jingjing, Huang Xinyi, et al. “Distribution of HDL Subgroups in Patients with H-type Hypertension and Its Impact on the Anti-inflammatory Function of Endothelial Cells.” Chinese Journal of Arteriosclerosis, 2023.

These publications are frequently cited by researchers exploring the links between metabolic dysfunction, arrhythmias, and cardiovascular inflammation.

🏅 AWARDS AND HONORS

  • Excellence Award, 4th National Undergraduate Anesthesiology Knowledge Competition (2018)

  • First Prize, Anesthesiology Imaging Professional Skills Competition Finals (2018)

  • Moral and Ethical Scholarship, Guangdong Medical University (2019)

  • Excellent Student Cadre, Guangdong Medical University (2017-2019)

  • Third-class Scholarship, Sun Yat-sen University (2020-2022)

  • Multiple awards recognizing her volunteerism, refereeing, and leadership contributions.

🌱 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Huang aspires to advance clinical strategies for obesity management in cardiovascular care, aiming to reduce the global burden of atrial fibrillation. She also seeks to explore AI-driven statistical tools and big data analytics to better predict cardiovascular outcomes.

With a strong passion for photography and life documentation, she continues to balance her rigorous scientific career with creative pursuits, inspiring a holistic approach to well-being and professional fulfillment.

📑 NOTABLE PUBLICATION

"Association of Body Mass Index and Abdominal Obesity with Incidence of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction"

Authors: Xinyi Huang; Xiao Liu; Yuan Jiang; Zhengyu Cao; Maoxiong Wu; Zhiteng Chen; Runlu Sun; Peng Yu; Jianyong Ma; Wengen Zhu
Journal: Current Medicinal Chemistry
Year: 2025

 

Jian Wang | Vascular regeneration | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Jian Wang | Vascular regeneration | Best Researcher Award

Yunnan University of Chinese Medicine | China

Author Profile:

Scopus

🌟 JIAN WANG: PIONEER IN TRADITIONAL CHINESE MEDICINE FOR NEUROLOGICAL HEALTH

🎓 EARLY ACADEMIC PURSUITS

Jian Wang embarked on his academic journey with a profound interest in the integration of Traditional Chinese Medicine (TCM) and modern neurological science. From the outset of his career, he demonstrated exceptional dedication to understanding the molecular and clinical pathways underlying neurological disorders. His educational background, though not explicitly detailed, reflects extensive scholarly preparation, equipping him to contribute significantly to both basic and clinical research in the realm of stroke and cerebral ischemia.

🧑‍⚕️ PROFESSIONAL ENDEAVORS

Jian Wang serves as a Discipline Leader and Technological Innovation Talent of Yunnan Province and is recognized as a Senior Talent in Traditional Chinese Medicine of Yunnan Province. He is currently affiliated with Yunnan University of Chinese Medicine, where he actively leads research teams, mentors young scientists, and advances the field of integrative neurology. His leadership roles underscore his commitment to elevating the scientific standing of Traditional Chinese Medicine both regionally and nationally.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON VASCULAR REGENERATION

Professor Wang's research is rooted in neuroprotection, stroke therapy, and inflammatory response modulation, using both experimental models and clinical applications of TCM. His focus spans:

  • Cuproptosis mechanisms in stroke pathogenesis 🧪

  • Electroacupuncture's effects on inflammation and neural regeneration ⚡

  • Network pharmacology and molecular docking for TCM compounds 🌿

  • Gut microbiota's role in osteoarthritis and brain health 🦠

  • Innovative TCM formulations for cognitive impairment and nephritis 🧠

Through these endeavors, he bridges modern biomedical science with classical Chinese therapeutics, enhancing treatment modalities for cerebral ischemia, stroke, and neuroinflammatory disorders.

📚 ACADEMIC CITES AND PUBLICATIONS

Jian Wang has co-authored numerous high-impact publications in esteemed journals such as Frontiers in Molecular Neuroscience, Neuroreport, and the American Journal of Chinese Medicine. Key articles include:

  • Studies on cuproptosis in stroke (Front Mol Neurosci, 2024)

  • Mechanistic insights on electroacupuncture (Neuroreport, 2025)

  • Gut microbiota links to osteoarthritis (Am J Chin Med, 2025)

  • TCM compound analyses using network pharmacology (Chem Biodivers, 2025)

These publications reflect his role as a thought leader in the evolving dialogue between Eastern and Western medical sciences.

🔍 RESEARCH PROJECTS AND SCIENTIFIC LEADERSHIP

Jian Wang has been entrusted with several prestigious research grants, including:

  • National Natural Science Foundation of China (NSFC) projects exploring electroacupuncture's role in nerve regeneration.

  • Yunnan Provincial Science and Technology Department initiatives focusing on inflammatory pathways such as NF-κB, NLRP3, and NAMPT in stroke models.

As a Principal Investigator, his projects not only advance basic science but also hold direct clinical implications for stroke rehabilitation and neurological recovery.

🌏 IMPACT AND INFLUENCE

Beyond his individual research achievements, Jian Wang plays a pivotal role in mentoring emerging researchers in Traditional Chinese Medicine. His work influences clinical practices in Yunnan Province and contributes to international scientific dialogues on stroke management, neuroinflammation, and integrative medicine.

His studies on electroacupuncture, paeony glucosides, and Ligusticum wallichii-Borneol combinations are referenced by scholars exploring alternative therapeutic strategies for stroke, vasculitis nephritis, and neurodegeneration.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Jian Wang's enduring legacy lies in his pioneering integration of TCM and neuroscience, setting a standard for multidisciplinary approaches to brain health. Looking ahead, his ongoing projects aim to further elucidate:

  • The regenerative pathways triggered by TCM therapies,

  • Novel targets for post-stroke neurorehabilitation,

  • Expanded clinical trials validating acupuncture and herbal treatments for neurological diseases.

His vision encompasses making Traditional Chinese Medicine a globally recognized and scientifically validated option for treating complex neurological conditions.

📑NOTABLE PUBLICATIONS

"Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities"

Authors: Xi Y, Wang Z, Wei Y, Xiao N, Duan L, Zhao T, Zhang X, Zhang L, Wang J, Li Z, Qin D
Journal: American Journal of Chinese Medicine
Year: 2025

"Cuproptosis in stroke: focusing on pathogenesis and treatment"

Authors: Xing L, Wang Z, Hao Z, Pan P, Yang A, Wang J
Journal: Frontiers in Molecular Neuroscience
Year: 2024

 

Yan Shi | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Yan Shi | Congenital Heart Defects | Best Researcher Award

Guangdong Provincial People's Hospital | China

Author Profile:

Scopus

Orcid

🌟 DR. YAN SHI: PIONEERING GENETICS RESEARCHER IN CARDIOVASCULAR DEVELOPMENT 🧬❤️

🎓 EARLY ACADEMIC PURSUITS

Yan Shi , a dedicated scientist from China, embarked on her academic journey in the field of life sciences with an undergraduate degree in Biological Engineering from Shenyang University (2008-2012). She continued to follow her passion for genetics at Hunan Normal University, earning a Master’s Degree in Genetics (2012-2014), and later completed her Ph.D. in Genetics in 2019. Throughout her studies, she developed a strong foundation in molecular biology, focusing on the genetic mechanisms underlying human diseases.

🏥 PROFESSIONAL ENDEAVORS

After obtaining her Ph.D., Dr. Yan Shi advanced her career through postdoctoral research at the Department of Pediatric Cardiac Surgery, Guangdong Provincial People's Hospital (2019-2024). In July 2024, she took on a significant role as a Researcher at the South China Key Laboratory of Structural Heart Disease, where she continues to contribute to groundbreaking cardiovascular research.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CONGENITAL HEART DEFECTS

Dr. Yan Shi's primary research focuses on the molecular mechanisms of congenital and familial heart diseases, especially:

  • Tetralogy of Fallot (TOF)

  • Familial Dilated Cardiomyopathy (DCM)

  • Wnt signaling pathways in cardiac development

  • Single coronary artery animal models

She has successfully led and participated in several national-level projects, including:

  • SORBS2's role in familial dilated cardiomyopathy via the AKT pathway (2024-2027).

  • NOTCH1 point mutations leading to Tetralogy of Fallot (2022-2024).

  • Establishing an animal model for single coronary artery using mice (2020-2022).

🏅 IMPACT AND INFLUENCE

Dr. Yan Shi’s work has been widely recognized in the academic community. She has published several influential papers in reputable journals as the first, co-first, or corresponding author, covering:

  • Wnt signaling and cardiomyocyte differentiation

  • NOTCH1 mutations in congenital heart disease

  • Genetic polymorphisms in BVES associated with Tetralogy of Fallot

Additionally, she was a contributor to a team that won the First-Class Guangdong Natural Science Award (2020) for their research on genes regulating cardiovascular development.

📚 ACADEMIC CITES

Her published research has been cited in various genetic, developmental biology, and cardiovascular journals. Some of her notable publications include:

  • "Variants and Molecular Mechanism of NOTCH1 in Congenital Heart Disease" – Corresponding Author

  • "Novel biphasic mechanism of the canonical Wnt signaling component PYGO2 promotes cardiomyocyte differentiation" – First Author

  • "Structure and function of Pygo in organ development" – First Author

🚀 LEGACY AND FUTURE CONTRIBUTIONS

As an emerging leader in the field of genetic cardiology, Dr. Yan Shi’s legacy is shaped by her contributions to understanding the genetic underpinnings of heart disease, which hold promise for improving clinical diagnostics and therapies for congenital heart conditions. Her future work is expected to explore further genetic pathways and their therapeutic targeting, potentially leading to personalized treatments for heart diseases.

📑 NOTABLE PUBLICATIONS

"Novel biphasic mechanism of the canonical Wnt signalling component PYGO2 promotes cardiomyocyte differentiation from hUCMSCs"

Authors: Y Shi, B Qin, X Fan, Y Li, Y Wang, W Yuan, Z Jiang, P Zhu, J Chen, Y Chen, F Li, Y Wan
Journal: Cell and Tissue Research
Year: 2023

"Structure and function of Pygo in organ development dependent and independent Wnt signalling"

Authors: Y Shi, X Wu, S Zhu, H Huang, J Zhuang, H Yuan, W Yuan, P Zhu
Journal: Biochemical Society Transactions
Year: 2020

Hua He | Coronary Artery Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hua He | Coronary Artery Disease | Best Researcher Award

Beijing Anzhen Hospital Affiliated to Capital Medical University | China

Author Profile:

Scopus

Orcid

🩺 DR. HUA HE – A PIONEERING HEART SPECIALIST

👶 EARLY ACADEMIC PURSUITS

Professor Hua He began her medical journey with a strong academic foundation. In 2006, she earned her Doctor of Medicine (M.D.) in Internal Medicine from the prestigious Peking Union Medical College, one of China’s top medical institutions. During her formative academic years, she displayed exceptional interest in cardiovascular health, laying the groundwork for her future contributions to the field of cardiology.

💼 PROFESSIONAL ENDEAVORS

Currently serving as a Professor and Chief Physician at Beijing Anzhen Hospital, Capital Medical University, Professor Hua He has dedicated her career to advancing clinical practices in cardiovascular medicine. Her professional role combines teaching, clinical care, and research, making her a multi-faceted leader in internal medicine and cardiology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CORONARY ARTERY DISEASE

Professor He’s research has consistently targeted some of the most critical conditions in cardiovascular health. Her expertise spans:

  • Coronary Heart Disease

  • Arrhythmia

  • Heart Failure

More recently, her pioneering investigations into mesenchymal stem cells and their derivatives have opened promising new avenues for the treatment of ischemic heart disease. As principal investigator, she has led numerous funded research projects and experimental studies in regenerative cardiology.

📚 ACADEMIC CITES AND PUBLICATIONS

Professor Hua He has authored over 10 peer-reviewed publications, each contributing valuable insights to the cardiology research community. Her work is frequently cited by researchers and clinicians exploring new frontiers in stem cell therapy, cardiac repair, and disease modulation. These citations reflect the credibility and scientific impact of her scholarly work.

🌍 IMPACT AND INFLUENCE

Her work has had a meaningful influence not only in clinical settings, where her therapies are contributing to patient recovery and rehabilitation, but also in academic spheres, where her findings continue to shape medical discourse on cardiovascular regeneration. As a mentor and educator, she plays a vital role in nurturing the next generation of physicians and researchers.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

With a career built on innovation and compassion, Professor Hua He is establishing a legacy as one of China’s most forward-thinking medical researchers in cardiovascular treatment. Looking ahead, she is expected to:

  • Expand her research on stem-cell-derived therapies

  • Enhance collaborative international studies

  • Influence cardiac treatment protocols worldwide

Her enduring commitment to research, education, and clinical practice ensures that her contributions will resonate for generations.

📑NOTABLE PUBLICATIONS

"Association between the (neutrophil + monocyte)/albumin ratio and all-cause mortality in sepsis patients: a retrospective cohort study and predictive model establishment according to machine learning"

Authors: T., Lulu Liu; Qian Ma; Guangzan Yu; Xuhou Ji; Hua He
Journal: BMC Infectious Diseases
Year: 2025

"Association between cardiorenal syndrome and depressive symptoms among the US population: a mediation analysis via lipid indices"

Authors: Guangzan Yu; Lulu Liu; Qian Ma; Hua He
Journal: Lipids in Health and Disease
Year: 2024

"Non-linear Association of CAR with all-Cause and Cardiovascular Mortality in Coronary Heart Disease: A Retrospective Cohort Study from NHANES"

Authors: Ming Ye; Guangzan Yu; Fusheng Han; Hua He
Journal: Clinical and Applied Thrombosis/Hemostasis
Year: 2024

Yajie Liu | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Yajie Liu | Cardiac Imaging | Best Researcher Award

Peking University Shenzhen Hospital | China

Author Profile:

Scopus

Orcid

🌟Prof. Dr. Yajie Liu – A Pioneer in Radiation Oncology & Cancer Research Excellence

🎓 EARLY ACADEMIC PURSUITS

Dr. Yajie Liu began her medical journey with a Bachelor of Medicine (1985–1990) from Norman Bethune University of Medical Sciences. Driven by a deep interest in oncology, she completed her Master's degree in Oncology (1993–1996) from Harbin Medical University, followed by a prestigious Ph.D. in Oncology (1998–2001) at the Peking Union Medical College.

To expand her global medical perspective, she completed a Visiting Scholar Fellowship in Radiation Oncology at Chonnam National University Hospital in South Korea in 2010.

🏥 PROFESSIONAL ENDEAVORS

Dr. Liu's medical career spans over three decades of dedicated clinical service and leadership:

  • 1990–1992: Resident Physician, ENT, First Workers' Hospital of Liaohe Petroleum Exploration Bureau

  • 1992–1998: Resident & Attending Physician, Radiation Oncology, The Third Affiliated Hospital of Harbin Medical University

  • 2001–2017: Progressed from Attending to Chief Physician and Deputy Director at Shenzhen People’s Hospital

  • 2017–Present: Chief Physician and Director, Department of Radiation Oncology, Peking University Shenzhen Hospital

Her ascent to leadership reflects a consistent trajectory of clinical excellence and patient-centered care in oncology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC IMAGING

Dr. Liu has led and co-led numerous research projects focused on:

  • Radiosensitization in Cancer Therapy

  • Hyperthermia and Serum Biomarkers

  • Radiation-Induced Brain Injury

  • Gene Assays for Breast Cancer Prognosis

  • Advanced Radiotherapy Strategies for Rectal and Colorectal Cancer

She has actively participated in national-level research, contributing to the Ministry of Science & Technology's high-impact projects on biomarkers and innovative radiotherapy techniques.

💡 RESEARCH FUNDING & PROJECT LEADERSHIP

As Principal Investigator (PI):

  • Shenzhen Science & Technology Bureau (4 Projects)

  • Shenzhen Health Commission (1 Project)

  • International Collaboration Grant (¥500K)

These funded projects demonstrate her innovative approach in blending clinical insight with technological advancement, especially in plasma therapy and hypoxic tumor sensitization.

🌐 PROFESSIONAL LEADERSHIP & ACADEMIC SERVICE

Dr. Liu holds key roles in multiple national and regional medical bodies:

  • Standing Committee Member, CRTOG

  • Committee Member, Radiotherapy Branch, Chinese Medical Doctor Association

  • Vice Chair, Lung Cancer Committee, Guangdong Women Doctors’ Association

  • Director, Radiotherapy Branch, Shenzhen Anti-Cancer Association

  • Council Member, Jiusan Society Shenzhen Chapter

Her positions reflect widespread recognition of her expertise and leadership in oncology.

📚 ACADEMIC CITES & COLLABORATIONS

While specific citation metrics are not provided here, Dr. Liu’s work on biomarkers, 21-gene assays, radiation injury, and colorectal cancer radiosensitization has contributed to national and international collaborations, significantly enriching the literature in radiation oncology.

🌍 IMPACT AND INFLUENCE

Dr. Liu's multidisciplinary research has influenced clinical protocols, improved patient outcomes, and inspired young oncologists across China. Her work on low-temperature plasma in radiosensitization reflects her commitment to cutting-edge translational oncology.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Yajie Liu's legacy is marked by:

  • Pioneering radiotherapy techniques

  • Mentoring future oncology leaders

  • Driving forward international research collaborations

Her future direction is expected to focus on precision oncology, AI-guided radiotherapy planning, and expanding patient-centered cancer care models.

📑 NOTABLE PUBLICATIONS

"Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress"

Authors: M Yang, D Shi, J Lyu, Y Pan, Y Lyv, X Chen, Y Ouyang, Y Liu, Y Li, L Song
Journal: Redox Biology
Year: 2025

"X-ray-activated nanoscintillators integrated with tumor-associated neutrophils polarization for improved radiotherapy in metastatic colorectal cancer"

Authors: H Li, J Zeng, Q You, M Zhang, Y Shi, X Yang, W Gu, Y Liu, N Hu, Y Wang, X Chen, J Mu
Journal: Biomaterials
Year: 2025